ISO 13485 Certification
Qvanteq completed ISO13485 Certification under the guidance of the notified body DEKRA. View Certificate.
Category: Archive
The Swiss coronary stent developer Qvanteq AG closes series B financing round of 4 million Swiss Francs to obtain clinical proof of concept and CE mark
Series B financing round Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to obtain clinical proof of concept in a “First-in-Man” study as well as CE market approval for Qvanteq’s own novel coronary […]
CTI Start-Up Label
Qvanteq AG was awarded with the “CTI Start-Up Label” in June 2012.
zkb pionierpreis technopark 2012 finalist
Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.
Qvanteq in “20minuten”: “Weniger Herzinfarkte dank neuer Stent-Technologie”
A portrait of Qvanteq AG was published in the the Swiss journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”. Full article (g).
Series A financing round
Qvanteq AG closed a Series A financing round to achieve proof of concept for its novel stent technology. The round was assisted by investiere.ch through a successful co-funding.
Venture Leaders USA Winner
Arik Zucker is one of the winners of the venture leader USA program.
Qvanteq AG won in venture kick
See link.